Prevalence of Coxsackievirus A6 and Enterovirus 71 in Hand, Foot and Mouth Disease in Nanjing, China in 2013

Pediatric Infectious Disease Journal

Volumn 34, Issue 9, 2015, Pages 951-957

  Hu, Ya Qian ^a,b   Xie, Guang Cheng ^b   Li, Dan Di ^b   Pang, Li Li ^b   Xie, Jing ^b   Wang, Peng ^a   Chen, Ying ^a   Yang, Jing ^a   Cheng, Wei Xia ^a   Zhang, Qing ^b   Jin, Yu ^a   Duan, Zhao Jun ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Chinese Center for Viral Disease Control and Prevention ^*  (China)

Author keywords

coxsackievirus A6; EV71; hand foot and mouth disease; human enterovirus

Indexed keywords

C REACTIVE PROTEIN; 5' UNTRANSLATED REGION; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILD HOSPITALIZATION; CHINA; COXSACKIEVIRUS A16; COXSACKIEVIRUS A6; ECHOVIRUS 6; ECHOVIRUS 9; ENTEROVIRUS 71; FEMALE; GENETIC TRAIT; GENOTYPE; HAND FOOT AND MOUTH DISEASE; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROAT CULTURE; VIRUS DETECTION; DNA SEQUENCE; ENTEROVIRUS; ENTEROVIRUS A; GENOTYPING TECHNIQUE; HAND, FOOT AND MOUTH DISEASE; INFANT; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; PHARYNX; PRESCHOOL CHILD; VIROLOGY;

5' UNTRANSLATED REGIONS; CHILD; CHILD, PRESCHOOL; CHINA; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; FEMALE; GENOTYPING TECHNIQUES; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; MALE; MOLECULAR EPIDEMIOLOGY; PHARYNX; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRAL STRUCTURAL PROTEINS;

EID: 84940034581     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000794     Document Type: Article

References (54)

1. Lau SK, Yip CC, Lung DC, et al. Detection of human rhinovirus C in fecal samples of children with gastroenteritis. J Clin Virol. 2012;53:290-296.
2. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778-790.
3. Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308-318.
4. Chang LY, Lin TY, Huang YC, et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 1999;18:1092-1096.
5. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341:929-935.
6. Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14:e1076-e1081.
7. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44:646-656.
8. Hosoya M, Kawasaki Y, Sato M, et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J. 2006;25:691-694.
9. Tu PV, Thao NT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733-1741.
10. Linsuwanon P, Puenpa J, Huang SW, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci. 2014;21:16.
11. Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7:94.
12. Zhang Y, Tan XJ, Wang HY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009;44:262-267.
13. Osterback R, Vuorinen T, Linna M, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009;15:1485-1488.
14. Russo DH, Luchs A, Machado BC, et al. Echovirus 4 associated to hand, foot and mouth disease. Rev Inst Med Trop Sao Paulo. 2006;48:197-199.
15. Zhu Z, Xu WB, Xu AQ, et al. Molecular epidemiological analysis of echovirus 19 isolated from an outbreak associated with hand, foot, and mouth disease (HFMD) in Shandong Province of China. Biomed Environ Sci. 2007;20:321-328.
16. Blomqvist S, Klemola P, Kaijalainen S, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48:49-54.
17. Lu QB, Zhang XA, Wo Y, et al. Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One. 2012;7:e52073.
18. Mirand A, Henquell C, Archimbaud C, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18:E110-E118.
19. Wei SH, Huang YP, Liu MC, et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis. 2011;11:346.
20. Gopalkrishna V, Patil PR, Patil GP, et al. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol. 2012;61(Pt 3):420-425.
21. Li JL, Yuan J, Yang F, et al. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J Infect. 2014;69:299-303.
22. Yang F, Yuan J, Wang X, et al. Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen, China. Clin Infect Dis. 2014;59: 1504-1505.
23. Han JF, Xu S, Zhang Y, et al. Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect. 2014;69:303-305.
24. Hongyan G, Chengjie M, Qiaozhi Y, et al. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr Infect Dis J. 2014;33:1302-1303.
25. Huang ML, Ho MS, Lee MS. Enterovirus 71 vaccine: when will it be available? J Formos Med Assoc. 2011;110:425-427.
26. Li JX, Mao QY, Liang ZL, et al. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines. 2014;13:609-618.
27. Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818-828.
28. Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024-2032.
29. Sapkal GN, Bondre VP, Fulmali PV, et al. Enteroviruses in patients with acute encephalitis, Uttar Pradesh, India. Emerg Infect Dis. 2009;15:295-298.
30. Ishiko H, Shimada Y, Yonaha M, et al. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J Infect Dis. 2002;185:744-754.
31. Chen Z, Sun H, Yan Y, et al. Epidemiological profiles of hand, foot, and mouth disease, including meteorological factors, in Suzhou, China. Arch Virol. 2015;160:315-321.
32. Liu W, Wu S, Xiong Y, et al. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One. 2014;9:e96051.
33. Tian H, Zhang Y, Sun Q, et al. Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3. PLoS One. 2014;9:e84233.
34. Zhu J, Luo Z, Wang J, et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One. 2013;8:e56318.
35. Lo SH, Huang YC, Huang CG, et al. Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect. 2011;44:252-257.
36. Xu M, Su L, Cao L, et al. Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis. 2013;13:489.
37. Tan X, Huang X, Zhu S, et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6:e25662.
38. Chong P, Liu CC, Chow YH, et al. Review of enterovirus 71 vaccines. Clin Infect Dis. 2015;60:797-803.
39. Sun S, Jiang L, Liang Z, et al. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccin Immunother. 2014;10:2885-2895.
40. Liu CC, Chow YH, Chong P, et al. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine. 2014;32:6177-6182.
41. Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease. Lancet. 2013;381:1968-1970.
42. Lu J, Zeng H, Zheng H, et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect. 2014;20:O442-O445.
43. He YQ, Chen L, Xu WB, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013;51:3560-3566.
44. Liu WD, Wu Y, Liang Q, et al. Epidemiological characteristics and temporal-spatial clustering analysis on hand-foot-mouth disease in Jiangsu province, 2009-2011. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:813-817.
45. Lau SK, Yip CC, Woo PC, et al. Human rhinovirus C: a newly discovered human rhinovirus species. Emerg Health Threats J. 2010;3:e2.
46. Lau SK, Yip CC, Tsoi HW, et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol. 2007;45:3655-3664.
47. Miller EK, Edwards KM, Weinberg GA, et al; New Vaccine Surveillance Network. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009;123:98-104.e1.
48. Loeffelholz MJ, Trujillo R, Pyles RB, et al. Duration of rhinovirus shedding in the upper respiratory tract in the first year of life. Pediatrics. 2014;134:1144-1150.
49. Wisdom A, Leitch EC, Gaunt E, et al. Screening respiratory samples for detection of human rhinoviruses (HRVs) and enteroviruses: comprehensive VP4-VP2 typing reveals high incidence and genetic diversity of HRV species C. J Clin Microbiol. 2009;47:3958-3967.
50. Chen YJ, Chang SC, Tsao KC, et al. Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities. PLoS One. 2012;7:e52432.
51. Fujimoto T, Iizuka S, Enomoto M, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis. 2012;18:337-339.
52. Flett K, Youngster I, Huang J, et al. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012;18:1702-1704.
53. Feder HM Jr, Bennett N, Modlin JF. Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis. 2014;14:83-86.
54. Huang WC, Huang LM, Lu CY, et al. Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J. 2013;10:209.